
Professor and Section Chief of Breast Surgery @pennsurgery, working to improve cancer treatment with combination immunotherapy & chemotherapy-free approaches
Pennsylvania, USA
Joined October 2018
- Tweets29
- Following166
- Followers174
- Likes136
Julia Tchou retweeted
#SITC22 | @tchou_julia (@pennsurgery) discusses PR after single radiotherapy + pembro in Ct1N0 #TNBC
⭐ Necrosis of tumor tissue suggests PR post-treatment
⭐ 3/10 pts achieved MPR
⭐ Future research inc lymph nodes and breast cancer subtype analysis
@sitcancer #ImmunoOnc #BCSM
Inaugural Women in Oncology Event @PennCancer @PennMedicine @pennsurgery yesterday was mentioned in Heolio.com. So grateful to work with amazing co-chairs @CharuAggarwalMD, @NehaVapiwala @lynn_schuchter – at Philadelphia, PA
Penn program addresses ‘barriers and bias’ unique to women in oncology Page 3 healio.com/hematology-oncolo…
Penn program addresses ‘barriers and bias’ unique to women in oncology Page 3 healio.com/hematology-oncolo…
Congratulations to Maria Pomponio MS1 & 2018 Harrison Scholar @pennsurgery @PennCancer and co-authors on her manuscript that was recently published in Annals of Surgical Oncology! – at Radnor Township, PA
3
Amazing event with amazing turnout @PennCancer 1st Women in Oncology (WIO) event. Our @pennsurgery @CBA_98 Dr. Aarons gave tips on clinical leadership roles to an audience of over 150 registered WIO participants. – at Philadelphia, PA
So honored to have our work @pennsurgery @PennPlasticSurg @PennMedicine @PennCancer featured in #ACSCC19 Daily Highlights. – at Pennsylvania, USA
Video interview of @tchou_julia for The #ACSCC19 daily highlights newsletter after her presentation of ERAS reducing narcotic requirement and length of stay in patients undergoing mastectomy with implant based reconstruction. https://xitter.cf/t.co/zPdxDzJhyc
4
Our @pennsurgery @PennCancer @PennMedicine last presentation “ERAS reduces periop narcotic requirement and length of stay after mastectomy with implant based reconstruction” was well received! Our breast group is honored to be so well represented (4 SF+2-e-posters)! #ACSCC19
We are so proud of Cassie Ye Huang MS1 @pennsurgery @PennCancer @PennMedicine for an outstanding presentation “Assessing patients’ knowledge of the impact of obesity on breast cancer risk” in SF307 Breast III #ACSCC19
We are so grateful to Cassie Ye Huang MS1 @pennsurgery @PennCancer @PennMedicine for presenting our work “effect of exercise on anti-tumor immunity” #ACSCC19
We are so proud of Maria Pomponio MS1 @pennsurgery @PennCancer @PennMedicine presenting our @tchou_julia work “does time to adjuvant chemotherapy affect outcomes in patients with TNBC” #acscc19 sp220 e-posterIV.
#ACSCC19 – at San Francisco, CA
Replying to @pennsurgery
@pennsurgery @PennCancer @PennMedicine we are so proud of our breast surgery fellow Susanna Nazarian presenting our @tchou_julia work “the use of MRI may exaggerate clinical stage and indication for neoadjuvant chemotherapy for HER2+ breast cancer” SF122 #cc2019
#acscc2019 – at San Francisco, CA
Replying to @PennCancer
@PennCancer @pennsurgery @PennMedicine so proud of Maria Pomponio MS1 for presenting our @tchou_julia work “Neoadjuvant chemotherapy does not provide benefit in HER2+ breast cancer with low disease burden”. She nailed it! SF122 #Cc2019
1
Julia Tchou retweeted
Replying to @PennCancer
@PennCancer @pennsurgery @PennMedicine so proud of Maria Pomponio MS1 for presenting our @tchou_julia work “Neoadjuvant chemotherapy does not provide benefit in HER2+ breast cancer with low disease burden”. She nailed it! SF122 #Cc2019
Julia Tchou retweeted
We are so proud to have Julia Tchou, MD, PhD, FACS on the @PennCancer team. She is on the front lines of innovative breast cancer research, and took some time to share with us the latest breakthroughs in #breastcancer treatments: spr.ly/601311Anb.
Julia Tchou retweeted
Finishing up strong with 5 outstanding presentations #ACS2018 #ACSCC2018
Replying to @AmCollSurgeons
1
3
@pennsurgery Keisha Dodman Penn resident just presented in SF Breast I
4






















